SimonMed Imaging has reached an agreement with SyntheticMR to utilize their advanced MR technology across many of its North American imaging sites.
SimonMed, one of the largest outpatient medical imaging providers and largest physician radiology practices in the United States, announced its implementation of SyntheticMR’s SyMRI software to support enhanced lesion detection and allow for quantitative MRI including the tracking of myelin development in pediatric patients and patients with Multiple Sclerosis.“The quantification of myelin through SyntheticMR is an example of our rapid progress beyond 3T MRI to use the latest MR technology to further improve diagnoses,” said Dr. John Simon, MD, Chief Executive of SimonMed. “I expect the